BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

3807

543298

VINEETLAB

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

VINEET LABORATORIES LTD performance

Today’s low

Today’s high

₹ 32.42 ₹ 33.49
₹ 32.79

52 week low

52 week high

₹ 30.31 ₹ 78.45
₹ 32.79

Open Price

₹ 33.27

Prev. Close

₹ 32.74

Volume (Shares)

10001.00

Total traded value

₹ 3.27

Upper Circuit

₹ 39.28

Lower Circuit

₹ 26.19

info

VINEET LABORATORIES LTD Share Price Update

As of the latest trading session, VINEET LABORATORIES LTD share price is currently at ₹ 32.51, which is down by ₹ -0.23 from its previous closing. Today, the stock has fluctuated between ₹ 32.42 and ₹ 33.49. Over the past year, VINEET LABORATORIES LTD has achieved a return of -42.27 %. In the last month alone, the return has been -4.06 %. Read More...

VINEET LABORATORIES LTD fundamentals


  • Market cap (Cr)

    30.20

  • P/E Ratio (TTM)

    -4.05

  • Beta

    1.05

  • Book Value / share

    27.18

  • Return on equity

    2.31%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    -5.71

info icon alternate text
  • Market cap (Cr)

    31.30

  • P/E Ratio (TTM)

    -4.05

  • Beta

    0.93

  • Book Value / share

    27.18

  • Return on equity

    2.31%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    -5.71

info icon alternate text

VINEET LABORATORIES LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 18.10
Operating Expense 23.80
Net Profit -5.71
Net Profit Margin (%) -31.54
Earnings Per Share (EPS) -6.19
EBITDA -4.10
Effective Tax Rate (%) -0.52
Particulars SEP 2024 (Values in Cr)
Revenue 18.96
Operating Expense 20.86
Net Profit -1.83
Net Profit Margin (%) -9.65
Earnings Per Share (EPS) -1.98
EBITDA -0.09
Effective Tax Rate (%) -7.01
Particulars JUN 2024 (Values in Cr)
Revenue 23.86
Operating Expense 26.41
Net Profit -2.13
Net Profit Margin (%) -8.92
Earnings Per Share (EPS) -2.31
EBITDA -0.42
Effective Tax Rate (%) 1.84
Particulars MAR 2024 (Values in Cr)
Revenue 37.05
Operating Expense 36.03
Net Profit 1.92
Net Profit Margin (%) 5.18
Earnings Per Share (EPS) 2.09
EBITDA 3.82
Effective Tax Rate (%) -34.26
Particulars DEC 2023 (Values in Cr)
Revenue 32.65
Operating Expense 35.00
Net Profit -2.07
Net Profit Margin (%) -6.33
Earnings Per Share (EPS) -2.24
EBITDA -0.62
Effective Tax Rate (%) 11.58
Particulars MAR 2024 (Values in Cr)
Revenue 150.59
Operating Expense 150.69
Net Profit 0.84
Net Profit Margin (%) 0.55
Earnings Per Share (EPS) 1.11
EBITDA 7.66
Effective Tax Rate (%) -133.33
Particulars MAR 2023 (Values in Cr)
Revenue 212.29
Operating Expense 210.39
Net Profit 1.25
Net Profit Margin (%) 0.58
Earnings Per Share (EPS) 1.36
EBITDA 7.78
Effective Tax Rate (%) 38.42
Particulars MAR 2022 (Values in Cr)
Revenue 191.17
Operating Expense 182.12
Net Profit 6.64
Net Profit Margin (%) 3.47
Earnings Per Share (EPS) 7.16
EBITDA 13.45
Effective Tax Rate (%) 28.98
Particulars MAR 2021 (Values in Cr)
Revenue 243.48
Operating Expense 239.80
Net Profit 1.78
Net Profit Margin (%) 0.73
Earnings Per Share (EPS) 2.18
EBITDA 8.54
Effective Tax Rate (%) 56.15
Particulars MAR 2024 (Values in Cr)
Book Value / Share 37.67
ROE % 2.31
ROCE % 6.59
Total Debt to Total Equity 1.10
EBITDA Margin 4.85
Particulars MAR 2023 (Values in Cr)
Book Value / Share 36.54
ROE % 3.74
ROCE % 8.51
Total Debt to Total Equity 0.86
EBITDA Margin 3.66
Particulars MAR 2022 (Values in Cr)
Book Value / Share 36.03
ROE % 22.19
ROCE % 22.35
Total Debt to Total Equity 0.65
EBITDA Margin 7.04
Particulars MAR 2021 (Values in Cr)
Book Value / Share 28.87
ROE % 13.18
ROCE % 32.64
Total Debt to Total Equity 0.46
EBITDA Margin 3.51
Particulars MAR 2020 (Values in Cr)
Book Value / Share 9.73
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.44
Total Assets 116.87
Total Liabilities 116.87
Total Equity 34.72
Share Outstanding 9219008
Price to Book Ratio 1.31
Return on Assets (%) 0.87
Return on Capital (%) 1.3
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.94
Total Assets 115.84
Total Liabilities 115.84
Total Equity 33.68
Share Outstanding 9219008
Price to Book Ratio 1.12
Return on Assets (%) 1.08
Return on Capital (%) 1.93
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 18.11
Total Assets 133.31
Total Liabilities 133.31
Total Equity 33.21
Share Outstanding 9219008
Price to Book Ratio 1.32
Return on Assets (%) 4.97
Return on Capital (%) 11.11
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.10
Total Assets 108.74
Total Liabilities 108.74
Total Equity 26.61
Share Outstanding 9219008
Price to Book Ratio 0.00
Return on Assets (%) 1.63
Return on Capital (%) 4.55
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.39
Total Liabilities 0.39
Total Equity 0.39
Share Outstanding 410000
Price to Book Ratio 0.00
Return on Assets (%) -2.78
Return on Capital (%) -2.78
Particulars MAR 2024 (Values in Cr)
Net Income 0.36
Cash from Operations -11.17
Cash from Investing 0.33
Cash from Financing 10.69
Net change in Cash -0.40
Free Cash Flow -10.94
Particulars MAR 2023 (Values in Cr)
Net Income 2.02
Cash from Operations -6.62
Cash from Investing -6.68
Cash from Financing 0.27
Net change in Cash -16.02
Free Cash Flow 1.00
Particulars MAR 2022 (Values in Cr)
Net Income 9.34
Cash from Operations 10.81
Cash from Investing -3.67
Cash from Financing 11.95
Net change in Cash 15.90
Free Cash Flow 10.81
Particulars MAR 2021 (Values in Cr)
Net Income 4.05
Cash from Operations 26.63
Cash from Investing -7.80
Cash from Financing 18.61
Net change in Cash 38.29
Free Cash Flow 26.63
Particulars MAR 2020 (Values in Cr)
Net Income -0.01
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2959.45 58.70 29.97 50134.87 1924.30 / 3147.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

VINEET LABORATORIES LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
32.79 0.15 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 33.40
  • 26 Days 34.70
  • 10 Days 33.70
  • 50 Days 37.50
  • 12 Days 33.80
  • 100 Days 42.70
  • 20 Days 34.20
  • 200 Days 48.20
33.61 PIVOT

First Support

31.73

First Resistance

34.62

Second Support

30.72

Second Resistance

36.50

Third Support

28.84

Third Resistance

37.51

RSI

41.49

ADX

4.52

MACD

-0.95

Williams % R

-86.93

Commodity Channel Index (CCI)

-98.73

Date

2025-04-30

Week

19625.00

Same Day

3951.00

Month

18874.00

1 Year

1.06

3 Year

0.81

Over 1 Month

-4.06%

down

Over 1 Year

-42.27%

down

Over 3 Months

-36.15%

down

Over 3 Years

-17.24%

down

Over 6 Months

-41.24%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

VINEET LABORATORIES LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
64.15%
Promoter Holdings
35.84%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Venkata Ramana Gaddam 830207.0 (9.01%) Shareholding of Promoter and Promoter Group
Venkata Rama Gaddam 547961.0 (5.94%) Shareholding of Promoter and Promoter Group
Satyanarayana Raju Bhupathiraju 519487.0 (5.63%) Shareholding of Promoter and Promoter Group
Rajesh Poddar 413256.0 (4.48%) Public Shareholding
A Prabhakar Raju 357205.0 (3.87%) Shareholding of Promoter and Promoter Group
A Srinivasa Raju 254972.0 (2.77%) Shareholding of Promoter and Promoter Group
Alluri Maithili 204521.0 (2.22%) Shareholding of Promoter and Promoter Group
A Ranga Raju 192093.0 (2.08%) Shareholding of Promoter and Promoter Group
Alluri Anantha Laxmi 165891.0 (1.8%) Shareholding of Promoter and Promoter Group
Wessel Consultancy Private Limited 166000.0 (1.8%) Public Shareholding
Dheeraj Kumar Lohia 117902.0 (1.28%) Public Shareholding
Vineet Laboratories Ltd - Physical Shares Account 93813.0 (1.02%) Public Shareholding
Penmetsa Venkata Krishnam Raju 85988.0 (0.93%) Shareholding of Promoter and Promoter Group
P Kishore Raju 74312.0 (0.81%) Shareholding of Promoter and Promoter Group
Gaddam Srinivasarao 36233.0 (0.39%) Shareholding of Promoter and Promoter Group
V Varaprasada Rao 17979.0 (0.2%) Shareholding of Promoter and Promoter Group
Gaddam Balaji 16993.0 (0.18%) Shareholding of Promoter and Promoter Group
Kandula Murali Mohan 745.0 (0.01%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

VINEET LABORATORIES LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2022 1.0 Final 20 Sep 2022 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2022 1.0 Final 20 Sep 2022 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

VINEET LABORATORIES LTD Share Price

Vineet Laboratories Limited (Formerly known as Ortin Laboratories Limited) is a manufacturing company of intermediates useful for the manufacture of active pharmaceutical ingredients. The Company was incorporated on 10 November 2016 and operates in the business of in the manufacture of Drug Intermediates & Bulk Dugs.

The production unit located at Malkapur Village, Yadadri- Bhuvanagiri District in Telangana State, India, is a multipurpose facility well equipped with stainless steel and glass-lined reactors with total volume of 230KL, of different volumes to suit any batch size. Special provisions are made to carry out reactions at very low temperature (up to -100°C). The Company is also specialized in manufacturing and handling pyrophoric chemicals like n-Butyl Lithium.

The Company export the API intermediates, fine chemicals and custom synthesis molecules. The Company is interested in collaborating with exporters who want high quality products for export to other countries. In addition to the list of products enlisted in the website, the Company can manufacture as per customer requirements ,in case having any specific requirement.

The Company constructed a warehouse with facilities for sampling both, dispensing booth, packing material room, rejected material room, intermediate room and a day storage for dispensed material 20 calibrated storage tanks from 10 KL to 40 KL available to store various solvents in dedicated tanks. All tanks are equipped with sprinklers and bund walls.

The multipurpose facility of the Company is well equipped with stainless steel and glass-lined reactors with total volume of 230 KL, of different volumes to suit any batch size. These reactors are provided with primary and secondary condensers, azeotropic boxes with facility to continue distillation under vacuum. Special provisions are made to carry out reactions at very low temperature up to -100°C and under inert atmosphere like nitrogen. Special equipment is in place to carryout reactions at high temperatures up to 250°C. Molecular distillation at hundred kilo batch size can be carried out. The Company is also specialized in manufacturing and handling pyrophoric chemicals like n-Butyl Lithium.

In 2020-21, the Company had two divisions - Formulations Division and API Intermediates Division. The erstwhile Company i.e. Ortin Laboratories Limited demerged the API Intermediates Division to the Company i.e. Vineet Laboratories Limited through the Scheme of Arrangement for Demerger in December, 2020.

The Company is specialized in pharmaceutical intermediates & fine chemicals. It is widely acknowledged for its abilities in product
development & process technology and therefore is the preferred source for many multinational companies for their outsourcing requirements. Infrastructure is versatile & is specially designed to address the requirements of carrying out complex and hazardous chemical process safely and efficiently. Their personnel are highly skilled in handling different kind of process chemistry. The Company is associated with many domestic and overseas customers like Gilead Sciences, USA, Teva, Mylan Laboratories Ltd., Hyderabad, Orchid Chemicals And Pharmaceuticals Ltd., Hetero Drugs, Cipla Limited, Jubilant Organosys Ltd., etc.

Parent organization Indian Private
NSE symbol VINEETLAB
Founded 2016
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Vineet Laboratories Ltd?

Answer Field

The share price of Vineet Laboratories Ltd for NSE is ₹ 32.51 and for BSE is ₹ 33.98.

What is the Market Cap of Vineet Laboratories Ltd?

Answer Field

The market cap of Vineet Laboratories Ltd for NSE is ₹ 30.20 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Vineet Laboratories Ltd?

Answer Field

The 52 Week High and Low of Vineet Laboratories Ltd for NSE is ₹ 78.45 and ₹ 30.31 and for BSE is ₹ 78.48 and ₹ 30.00.

How to Buy Vineet Laboratories Ltd share?

Answer Field

You can trade in Vineet Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Vineet Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -42.27%.

What is the Current Share Price of Vineet Laboratories Ltd?

Answer Field

Vineet Laboratories Ltd share price is for NSE ₹ 32.51 & for BSE ₹ 33.98 as on Apr 30 2025 03:29 PM.

What is the Market Cap of Vineet Laboratories Ltd Share?

Answer Field

The market cap of Vineet Laboratories Ltd for NSE ₹ 30.20 & for BSE ₹ 0.0 as on Apr 30 2025 03:29 PM.

What is the P/E Ratio of Vineet Laboratories Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Vineet Laboratories Ltd share is -4.05.

What is the PB ratio of Vineet Laboratories Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Vineet Laboratories Ltd share is 27.18.

How to Buy Vineet Laboratories Ltd Share?

Answer Field

You can trade in Vineet Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vineet Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Vineet Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vineet Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|